Last reviewed · How we verify
NCT03102866
Aerobic and Strength Training Exercise in Improving Fitness and Arm Health During and After Radiation Therapy in Patients With Stage II-III Breast Cancer
NA trial testing Best Practice in Stage II Breast Cancer in 4 participants. Completed in 4 April 2019.
4 April 2019
Quick facts
| Lead sponsor | Ohio State University Comprehensive Cancer Center |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 4 |
| Start date | 30 August 2017 |
| Primary completion | 4 April 2019 |
| Estimated completion | 4 April 2019 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Best Practice
- Exercise Intervention
- Quality-of-Life Assessment
- Questionnaire Administration
Conditions studied
- Stage II Breast Cancer — all drugs for Stage II Breast Cancer →
- Stage IIA Breast Cancer — all drugs for Stage IIA Breast Cancer →
- Stage IIB Breast Cancer — all drugs for Stage IIB Breast Cancer →
- Stage III Breast Cancer — all drugs for Stage III Breast Cancer →
Sponsor
Ohio State University Comprehensive Cancer Center
Who can join
Eligibility, female only, with Stage II Breast Cancer or Stage IIA Breast Cancer. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This randomized pilot phase I/II trial studies how well aerobic and strength training exercise works in improving fitness and arm health during and after radiation therapy consisting of regional nodal radiation in patients with stage II-III breast cancer. Aerobic and strength training exercise training during and after radiation therapy may reduce treatment related toxicities and improve adherence to exercise long term in patients with breast cancer.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Exercise interventions for people undergoing multimodal cancer treatment that includes surgery.
Loughney LA, West MA, Kemp GJ, Grocott MP, et al · · 2018 · cited 29× · PMID 30536366 · DOI 10.1002/14651858.cd012280.pub2
Verify or expand the search:
- PubMed search for NCT03102866
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Best Practice
Trials testing the same drug.
- NCT07126548 — A Point of Prostate Cancer Diagnosis Virtual Reality Assistant Intervention in Supporting Newly Diagnosed Black Men · NA · not yet recruiting
- NCT07022678 — Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia · Phase 3 · not yet recruiting
- NCT07225855 — Geriatric Assessment and Management for Older Adults Undergoing Chemotherapy and Radiation Therapy for Head and Neck Can · NA · not yet recruiting
- NCT05874297 — Online Nutrition Education to Decrease the Side Effects of Chemotherapy in Patients With Breast Cancer · NA · not yet recruiting
- NCT07176000 — Tailored Patient Navigation to Improve the Uptake of Lung Cancer Screening in Tribal Communities in Western Washington S · NA · not yet recruiting
Other recruiting trials for Stage II Breast Cancer
Currently open trials in the same condition.
- NCT07095114 — A Study of Disappearing Markers for Daily Radiation Treatment Delivery for Breast Cancer Patients. · NA · recruiting
- NCT07042581 — A Study of Revaree Plus in People With Breast Cancer · Phase 4 · recruiting
- NCT06087120 — Predicting BReast cAncer Response to neoadjuVant Therapy by ctDNA Assessment · recruiting
- NCT05535192 — TeleHealth Resistance Exercise Intervention to Preserve Dose Intensity and Vitality in Elder Breast Cancer Patients · NA · recruiting
- NCT05595577 — Improving Exercise Capacity With a Tailored Physical Activity Intervention · NA · recruiting
Other Ohio State University Comprehensive Cancer Center trials
Trials by the same sponsor.
- NCT06816979 — Lumbar Punctures for the Detection of ctDNA in the Cerebrospinal Fluid of Patients With Stage III and IV Non-Small Cell · NA · not yet recruiting
- NCT07529483 — Endoscopic Ultrasound-Guided Chemoablation for the Treatment of Pancreatic Cysts · Phase 2 · not yet recruiting
- NCT07455513 — A Novel Tobacco Cessation Resource for Smokers With a Diagnosed or Suspected Thoracic Cancer · NA · not yet recruiting
- NCT07217990 — Neoadjuvant Complete Response Customized Treatment Approach for Definitive Management of Breast Cancer · Phase 1, PHASE2 · not yet recruiting
- NCT07503925 — THRIVE Study: Understanding How Oral Nicotine Pouches Affect Public Health · Phase 4 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03102866 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Ohio State University Comprehensive Cancer Center
- Last refreshed: 14 December 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03102866.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing